KRAS and neoplasm: Tumor DNA analysis identified (a) a stop codon leading to loss of function of protein NOTCH1 (p.Q290*) and (b) a genomic amplification of KRAS, which results in overexpression of KRAS protein, activation of KRAS-MAPK pathway, and tumor progression [18].